Finland· FI-REL-REL8038
Sulfadiasal
A sulfadiazine product, registered in Finland by SALMED. The same ATC class is registered in 8 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Sulfadiazine is registered in 8 of 19 countries.
Countries holding a registration under ATC J01EC02 (sulfadiazine), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 5 of them publish a price we can compare per daily dose
Sulfadiazine · ATC J01EC02
8 / 19 countries
- Finlandprice
- Franceprice
- Germany
- Japan
- Norwayprice
- Spainprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of sulfadiazine costs, country by country.
Normalised to the WHO defined daily dose (0.6 g), the median price runs from $0.18 in France to $0.72 in Spain — a ×4.1 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Sulfadiazine · price per daily dose (0.6 g)
USD · FX 28 Sept 2026
- ES Spain$0.72
- FR France$0.18
The record
At a glance
Fimea (Finland)- Manufacturer
- SALMED
- Country
- Finland (FI)
- ATC code
- J01EC02
- ATC class
- Sulfadiazine
- Defined daily dose
- 0.6 g, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
97 interactions on record for sulfadiazine.
Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Sulfadiazine · interactions on record
97 records
- 5 severe
- 61 moderate
- 31 info
Most severe, free to view
- DicoumarolB01AA01severe
- WarfarinB01AA03severe
- Aminobenzoic acidD02BA01severe
- Aminolevulinic acidL01XD04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under J01EC02
Sulfadiazine, as other registers publish it.
- FinlandAdiazinSTAR
- FinlandAdiazinSchering Oy
- FinlandAdiazinSTAR
- NorwayAdiazineRecordati
- FranceADIAZINE 500 mg, compriméBOUCHARA-RECORDATI
- GermanySulfadiazin HeylHeyl Chemisch-Pharmazeutische Fabrik Gmbh & Co. Kg
- SpainSULFADIAZINA REIG JOFRE 500 MG COMPRIMIDOSLaboratorio Reig Jofre, S.A.
- United StatessulfADIAZINEChartwell RX, LLC
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7e2beaa9-8a17-4d5f-9a75-efcca1da702e GET /v1/drugs/7e2beaa9-8a17-4d5f-9a75-efcca1da702e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "0.6",
"form": "tabletti",
"route": null,
"ddd_unit": "g",
"strength": "500 mg",
"atc_label": "sulfadiatsiini",
"ma_number": "8192",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL8038",
"authorised_at": "1981-06-17"
}See everything about sulfadiazine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.